Stange EF - Search Results

1

Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients.

Schmidt KJ, Herrlinger KR, Emmrich J, Barthel D, Koc H, Lehnert H, Stange EF, Fellermann K, Büning J. Schmidt KJ, et al. Among authors: stange ef. Aliment Pharmacol Ther. 2013 Jan;37(1):129-36. doi: 10.1111/apt.12118. Epub 2012 Nov 5. Aliment Pharmacol Ther. 2013. PMID: 23121200 Free article.

2

Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease.

Fellermann K, Herrlinger KR, Witthoeft T, Homann N, Ludwig D, Stange EF. Fellermann K, et al. Among authors: stange ef. Transplant Proc. 2001 May;33(3):2247-8. doi: 10.1016/s0041-1345(01)01979-0. Transplant Proc. 2001. PMID: 11377517 Clinical Trial. No abstract available.

3

6-thioguanine--efficacy and safety in chronic active Crohn's disease.

Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Deibert P, Fellermann K, Greinwald R, Stange EF. Herrlinger KR, et al. Among authors: stange ef. Aliment Pharmacol Ther. 2003 Feb 15;17(4):503-8. doi: 10.1046/j.1365-2036.2003.01440.x. Aliment Pharmacol Ther. 2003. PMID: 12622758 Free article.

4

Tacrolimus--finally!

Herrlinger KR, Fellermann K, Stange EF. Herrlinger KR, et al. Among authors: stange ef. Gut. 2006 Sep;55(9):1224-5. doi: 10.1136/gut.2006.093302. Gut. 2006. PMID: 16905691 Free PMC article.

5

Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus.

Herrlinger KR, Barthel DN, Schmidt KJ, Büning J, Barthel CS, Wehkamp J, Stange EF, Fellermann K. Herrlinger KR, et al. Among authors: stange ef. Aliment Pharmacol Ther. 2010 May;31(9):1036-41. doi: 10.1111/j.1365-2036.2010.04267.x. Epub 2010 Feb 18. Aliment Pharmacol Ther. 2010. PMID: 20175769 Free article.

6

ABCB1 single-nucleotide polymorphisms determine tacrolimus response in patients with ulcerative colitis.

Herrlinger KR, Koc H, Winter S, Teml A, Stange EF, Fellermann K, Fritz P, Schwab M, Schaeffeler E. Herrlinger KR, et al. Among authors: stange ef. Clin Pharmacol Ther. 2011 Mar;89(3):422-8. doi: 10.1038/clpt.2010.348. Epub 2011 Feb 2. Clin Pharmacol Ther. 2011. PMID: 21289623

7

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues.

Schmidt KJ, Müller N, Dignass A, Baumgart DC, Lehnert H, Stange EF, Herrlinger KR, Fellermann K, Büning J. Schmidt KJ, et al. Among authors: stange ef. J Crohns Colitis. 2016 Jan;10(1):31-7. doi: 10.1093/ecco-jcc/jjv175. Epub 2015 Sep 28. J Crohns Colitis. 2016. PMID: 26419459

8

Twenty-five years of biologicals in IBD: What´s all the hype about?

Herrlinger KR, Stange EF. Herrlinger KR, et al. Among authors: stange ef. J Intern Med. 2021 Oct;290(4):806-825. doi: 10.1111/joim.13345. Epub 2021 Jul 21. J Intern Med. 2021. PMID: 34128571 Free article. Review.

9

The debated role for thiopurines in Crohn's disease.

Herrlinger KR, Stange EF. Herrlinger KR, et al. Among authors: stange ef. J Crohns Colitis. 2014 Feb;8(2):172-4. doi: 10.1016/j.crohns.2013.11.026. Epub 2013 Dec 15. J Crohns Colitis. 2014. PMID: 24342765

10

Response of refractory colitis to intravenous or oral tacrolimus (FK506).

Fellermann K, Tanko Z, Herrlinger KR, Witthoeft T, Homann N, Bruening A, Ludwig D, Stange EF. Fellermann K, et al. Among authors: stange ef. Inflamm Bowel Dis. 2002 Sep;8(5):317-24. doi: 10.1097/00054725-200209000-00002. Inflamm Bowel Dis. 2002. PMID: 12479646 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters